Curriculum Vitaes

shiino kenji

  (椎野 憲二)

Profile Information

Affiliation
School of Medicine, Faculty of Medicine, Fujita Health University

J-GLOBAL ID
201501009934692997
researchmap Member ID
7000012720

Misc.

 8
  • 平光伸也, 石黒良明, 松山裕宇, 山田健二, 加藤千雄, 加藤 茂, 野場万司, 植村晃久, 松原由朗, 吉田 哲, 可児 篤, 長谷川和生, 加藤久視, 徳田 衛, 松原史朗, 内山達司, 宮城島賢二, 森 一真, 木村 央, 加藤靖周, 松井 茂, 成瀬寛之, 椎野憲二, 北川文彦, 石井潤一, 尾崎行男
    血圧, 20(1) 94-99, 2013  
  • Shinya Hiramitsu, Kenji Miyagishima, Junichi Ishii, Shigeru Matsui, Hiroyuki Naruse, Kenji Shiino, Fumihiko Kitagawa, Yukio Ozaki
    JOURNAL OF CARDIOLOGY, 60(5-6) 395-400, Nov, 2012  
    Objectives: The clinical benefit of ezetimibe, an intestinal cholesterol transporter inhibitor, for treatment of postprandial hyperlipidemia was assessed in subjects who ingested a high-fat and high-glucose test meal to mimic westernized diet. Methods: We enrolled 20 male volunteers who had at least one of the following: waist circumference >= 85 cm, body mass index >= 25 kg/m(2), or triglycerides (TG) from 150 to 400 mg/dL. After 4 weeks of treatment with ezetimibe (10 mg/day), the subjects ingested a high-fat and high-glucose meal. Then changes in serum lipid and glucose levels were monitored after 0, 2, 4, and 6 h, and the area under the curve (AUC) was calculated for the change in each parameter. Results and conclusion: At 4 and 6 h postprandially, TG levels were decreased (p < 0.01) after 4 weeks of ezetimibe treatment, and the AUC for TG was also decreased (p < 0.01). Apolipoprotein B48 (apo-B48) levels at 4 and 611 postprandially were significantly decreased after ezetimibe treatment (p < 0.01 and p < 0.001, respectively), and the AUC for apo-B48 was also significantly decreased (p < 0.01). Blood glucose and insulin levels at 2 h postprandially were significantly decreased by ezetimibe (p < 0.01). The AUCs for blood glucose and insulin were also significantly decreased (p < 0.05 and p < 0.01, respectively). Since ezetimibe improved postprandial lipid and glucose metabolism, this drug is likely to be beneficial for dyslipidemia in patients with postprandial metabolic abnormalities. (C) 2012 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
  • 平光伸也, 石黒良明, 松山裕宇, 加藤千雄, 野場万司, 植村晃久, 松原由朗, 吉田 哲, 可児 篤, 加藤久視, 長谷川和生, 松原史朗, 内山達司, 加藤靖周, 松井 茂, 成瀬寛之, 宮城島賢二, 椎野憲二, 北川文彦, 尾崎行男, 石井潤一
    Progress in Medicine, 32(2) 337-344, 2012  
  • Eirin Sakaguchi, Akira Yamada, Kunihiko Sugimoto, Yoshihiro Ito, Kenji Shiino, Kayoko Takada, Masatsugu Iwase, Yukio Ozaki
    EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY, 12(6) 440-444, Jun, 2011  
    Aims We evaluated the usefulness of left atrial volume index (LAVI) and the degree of changes in LAVI (delta LAVI) during hospitalization for the prediction of prognosis after acute myocardial infarction (AMI). Methods and results We investigated 205 consecutive patients with first AMI. They underwent echocardiography on admission as well as at discharge. Delta LAVI was calculated by subtracting the value on admission from that at discharge. The primary endpoints were major cardiac events (MACE): cardiac death due to heart failure and heart failure hospitalization. During a mean follow-up of 26 months, MACE occurred in 29 patients. Patients were divided into two groups according to the optimal cut-off values of LAVI (32.0 mL/m(2)) at discharge and delta LAVI (2.5 mL/m(2)) derived from receiver operating characteristic curves, respectively; Group I: LAVI <= 32.0 mL/m(2), Group II: LAVI > 32.0 mL/m(2) and Group A: delta LAVI <= 2.5 mL/m(2), Group B: delta LAVI > 2.5 mL/m(2). In comparisons of two groups, respectively, the incidence of MACE between the groups showed significant differences [ Group I (3.8%) vs. Group II (32.0%): P < 0.001, log-rank, Group A (7.4%) vs. Group B (20.0%): P = 0.0079, log-rank]. In multivariate analysis, LAVI at discharge [risk ratio (RR): 1.077, 95% CI: 1.035-1.124, P = 0.0002] and delta LAVI (RR: 1.056, 95% CI: 1.012-1.108, P = 0.0109) were significant. LAVI > 32.0 mL/m(2) at discharge (sensitivity: 93%, specificity: 69%) and delta LAVI > 2.5 mL/m(2) (sensitivity: 79%, specificity: 50%) were predictors of MACE. Conclusion LAVI at discharge and delta LAVI would be useful predictors for MACE after first AMI.
  • 平光伸也, 宮城島賢二, 椎野憲二, 尾崎行男
    血圧, 18(11) 1144-1149, 2011  
  • 平光伸也, 石黒良明, 松山裕宇, 山田健二, 加藤千雄, 野場万司, 植村晃久, 松原由朗, 吉田 哲, 可児 篤, 長谷川和生, 加藤久視, 松原史朗, 内山達司, 加藤靖周, 松井 茂, 成瀬寛之, 宮城島賢二, 椎野憲二, 北川文彦, 石井潤一, 尾崎行男
    血圧, 17(8) 704-709, 2010  
  • 平光伸也, 平光精二, 宮城島賢二, 椎野憲二, 尾崎行男
    血圧, 17(1) 73-77, 2010  

Presentations

 34